Silodosin Capsule
Product Images NDC 60219-1420

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Silodosin (NDC 60219-1420). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Amneal Pharmaceuticals Ny Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structure (Silodosin Capsules 1)

Chemical structure of silodosin, showing its molecular framework with aromatic rings, amide, ether, and hydroxyl functional groups depicted in a two-dimensional skeletal formula.*

FDA Label Image

As (Silodosin Capsules 2)

A line graph showing silodosin concentration (ng/mL) over time (hours). The graph depicts changes in silodosin levels from 0 to 24 hours, with error bars indicating variability at each time point.*

FDA Label Image

Fg (Silodosin Capsules 3)

A line graph comparing change from baseline in IPSS total score between placebo and Silodosin 8 mg groups over time points up to 84 days or last observation carried forward (LOCF). The Silodosin 8 mg group shows a greater decrease in score compared to placebo, with statistical significance indicated.*

FDA Label Image

Jh (Silodosin Capsules 4)

A line graph comparing the change from baseline in IPSS Total Score over time between Placebo and Silodosin 8 mg groups. The x-axis represents days (3, 3.5, 7, 14, 28, 84/LOCF), and the y-axis shows score changes, with Silodosin 8 mg showing a greater reduction compared to placebo, indicating improved symptom scores over time.*

FDA Label Image

Ad (Silodosin Capsules 5)

A line chart comparing the change from baseline in Cmax (mL/sec) over days between Silodosin 8 mg and placebo. The x-axis shows days (0, 1, 7, 14, 28, and 84/LOCF), while the y-axis shows change in Cmax. The Silodosin group shows a higher increase in Cmax compared to placebo, with statistically significant differences marked.*

FDA Label Image

Uy (Silodosin Capsules 6)

A line graph comparing the change from baseline in Cmax (mL/sec) over time between placebo and Silodosin 8 mg groups. The x-axis represents days from baseline to day 84, and the y-axis shows the change in Cmax. Data points show an increase in Cmax for Silodosin 8 mg compared to placebo, with significant differences indicated on days 1 and 84.*

FDA Label Image

4 mg 30 Count Label (Silodosin Capsules 7)

Silodosin Capsules 4 mg oral capsules by Amneal Pharmaceuticals NY LLC. The label indicates each capsule contains 4 mg Silodosin and includes storage instructions to keep between 20° to 25°C (68° to 77°F) with permitted excursions. The package contains 30 capsules for prescription use only. Additional handling and dosage information is provided on the label.*

FDA Label Image

8 mg 30 Count Label (Silodosin Capsules 8)

Silodosin Capsules 8 mg oral capsules label from Amneal Pharmaceuticals NY LLC. The label includes the dosage strength of 8 mg per capsule, a supply of 30 capsules, and storage instructions advising to keep between 20° to 25°C, with excursions permitted between 15° to 30°C. It also states Rx only, a barcode, and cautions to protect from light and moisture and keep out of reach of children.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.